0001209191-22-021330.txt : 20220328 0001209191-22-021330.hdr.sgml : 20220328 20220328165254 ACCESSION NUMBER: 0001209191-22-021330 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220322 FILED AS OF DATE: 20220328 DATE AS OF CHANGE: 20220328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GLENN JOHN CENTRAL INDEX KEY: 0001253497 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37854 FILM NUMBER: 22776117 MAIL ADDRESS: STREET 1: 7900 HOPYARD ROAD STREET 2: APT 210 CITY: PLEASANTON STATE: CA ZIP: 94577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EKSO BIONICS HOLDINGS, INC. CENTRAL INDEX KEY: 0001549084 STANDARD INDUSTRIAL CLASSIFICATION: GENERAL INDUSTRIAL MACHINERY & EQUIPMENT, NEC [3569] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1414 HARBOUR WAY SOUTH STREET 2: SUITE 1201 CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 510-984-1761 MAIL ADDRESS: STREET 1: 1414 HARBOUR WAY SOUTH STREET 2: SUITE 1201 CITY: RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: PN Med Group Inc DATE OF NAME CHANGE: 20120503 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-22 0 0001549084 EKSO BIONICS HOLDINGS, INC. EKSO 0001253497 GLENN JOHN C/O EKSO BIONICS HOLDINGS, INC. 1414 HARBOUR WAY SOUTH, SUITE 1201 RICHMOND CA 94804 0 1 0 0 Chief Financial Officer Common Stock 2022-03-22 4 S 0 3462 2.8197 D 35130 D Represents shares sold by the Reporting Person on March 22, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of restricted stock awards reported by the Reporting Person in Form 4s filed with the Commission on February 22, 2022 and March 5, 2021. The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.88 to $2.81, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request. /s/ Jerome Wong, as Attorney-in-Fact 2022-03-28